Skip to main content



Page 1 of 9

  1. Content type: Study Protocol

    There is existing evidence on whether and to what degree regular exercise training improves the quality of life (QoL) among cancer survivors. However, in regards to patients with high-grade glioma (HGG; WHO gr...

    Authors: Dominik Cordier, Markus Gerber and Serge Brand

    Citation: Cancer Communications 2019 39:46

    Published on:

  2. Content type: Original article

    The prevalence of Lynch syndrome and screening strategies for this disorder in Chinese patients with endometrial cancer have seldom been investigated. Such data would be essential for the screening, prevention...

    Authors: Xiaopei Chao, Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong, Yalan Bi and Jinghe Lang

    Citation: Cancer Communications 2019 39:42

    Published on:

  3. Content type: Original article

    Promising efficacy and manageable toxicity of docetaxel-based concurrent chemoradiotherapy (CCRT) were reported in head and neck cancer. In addition, the effect of CCRT in combination with cisplatin and/or 5-f...

    Authors: Jun-Fang Liao, Qun Zhang, Xiao-Jing Du, Mei Lan, Shan Liu, Yun-Fei Xia, Xiu-Yu Cai and Wei Luo

    Citation: Cancer Communications 2019 39:40

    Published on:

  4. Content type: Original article

    The JACOB trial (NCT01774786) was a double-blinded, placebo-controlled, randomized, multicenter, international, phase III trial evaluating the efficacy and safety of adding pertuzumab to trastuzumab and chemot...

    Authors: Tianshu Liu, Yanru Qin, Jin Li, Ruihua Xu, Jianming Xu, Shujun Yang, Shukui Qin, Yuxian Bai, Changping Wu, Yixiang Mao, Haiyan Wu, Yilin Ge and Lin Shen

    Citation: Cancer Communications 2019 39:38

    Published on:

  5. Content type: Review

    On May 8, 2018, the China National Medical Products Administration (NMPA) approved anlotinib, an orally administered anti-angiogenesis inhibitor, for the treatment of patients with advanced non-small cell lung...

    Authors: Ming Zhou, Xiaoyuan Chen, Hong Zhang, Lin Xia, Xin Tong, Limin Zou, Ruimin Hao, Jianhong Pan, Xiao Zhao, Dongmei Chen, Yuanyuan Song, Yueli Qi, Ling Tang, Zhifang Liu, Rong Gao, Yuankai Shi…

    Citation: Cancer Communications 2019 39:36

    Published on:

  6. Content type: Original article

    The prognosis of gastric cancer patients with a limited number of pathologically examined lymph nodes (eLN, < 16) is dismal compared to those with adequately eLN (≥ 16), yet they are still classified within th...

    Authors: Sharvesh Raj Seeruttun, Lipu Xu, Fangwei Wang, Xiaodong Yi, Cheng Fang, Zhimin Liu, Wei Wang and Zhiwei Zhou

    Citation: Cancer Communications 2019 39:32

    Published on:

  7. Content type: Original article

    Patients in who with insufficient number of analysed lymph nodes (LNs) are more likely to receive an incorrect LN staging. The ability to calculate the overall probability of undiagnosed LN involvement errors ...

    Authors: Carlos Fortea-Sanchis, Erica Forcadell-Comes, David Martínez-Ramos and Javier Escrig-Sos

    Citation: Cancer Communications 2019 39:31

    Published on:

  8. Content type: Original article

    A phase II clinical trial of the comparison between eribulin plus gemcitabine (EG) and paclitaxel plus gemcitabine (PG) as first-line chemotherapy for patients with metastatic breast cancer (MBC) found that th...

    Authors: Ji-Yeon Kim, Seri Park, Seock-Ah Im, Sung-Bae Kim, Joohyuk Sohn, Keun Seok Lee, Yee Soo Chae, Ki Hyeong Lee, Jee Hyun Kim, Young-Hyuck Im, Tae-Yong Kim, Kyung-Hun Lee, Jin-Hee Ahn, Gun Min Kim, In Hae Park, Soo Jung Lee…

    Citation: Cancer Communications 2019 39:29

    Published on:

  9. Content type: Original article

    The 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) regimen is the standard first-line treatment for metastatic colorectal cancer (mCRC), however, the optimal second-line regimen for KRAS wild-type mCRC patie...

    Authors: Yuankai Shi, Jin Li, Jianming Xu, Yan Sun, Liwei Wang, Ying Cheng, Wei Liu, Guoping Sun, Yigui Chen, Li Bai, Yiping Zhang, Xiaohui He, Yi Luo, Zhehai Wang, Yunpeng Liu, Qiang Yao…

    Citation: Cancer Communications 2019 39:28

    Published on:

  10. Content type: Original article

    Oxaliplatin, irinotecan, 5-fluorouracil, and l-leucovorin (FOLFIRINOX) has become one of the first-line treatment options for advanced pancreatic cancer (PC). However, the relatively high rate of grade 3 or 4 adv...

    Authors: Zhi-Qiang Wang, Fei Zhang, Ting Deng, Le Zhang, Fen Feng, Feng-Hua Wang, Wei Wang, De-Shen Wang, Hui-Yan Luo, Rui-Hua Xu, Yi Ba and Yu-Hong Li

    Citation: Cancer Communications 2019 39:26

    Published on:

  11. Content type: Original article

    In the post-Z0011 trial era, the need to perform surgical axillary staging for early-stage breast cancer patients, who are treated with breast-conserving therapy (BCT), is being questioned. We conducted a retr...

    Authors: Jin Wang, Hailin Tang, Xing Li, Cailu Song, Zhenchong Xiong, Xi Wang, Xiaoming Xie and Jun Tang

    Citation: Cancer Communications 2019 39:25

    Published on:

  12. Content type: Original article

    Tumor hypoxia is associated with metastasis and resistance to chemotherapy and radiotherapy. Genes involved in oxygen-sensing are clinically relevant and have significant implications for prognosis. In this st...

    Authors: Wai Hoong Chang, Donall Forde and Alvina G. Lai

    Citation: Cancer Communications 2019 39:23

    Published on:

  13. Content type: Original article

    Radical cystectomy and urinary diversion remains the standard surgical treatment for patients with muscle-invasive or high-risk or recurrent non-muscle-invasive bladder cancer. Although this approach prolongs ...

    Authors: Zhiyong Li, Zhuowei Liu, Kai Yao, Zike Qin, Hui Han, Yonghong Li, Pei Dong, Yunlin Ye, Yanjun Wang, Zhiming Wu, Zhiling Zhang and Fangjian Zhou

    Citation: Cancer Communications 2019 39:19

    Published on:

  14. Content type: Original article

    Internal tandem duplications (ITD) within the juxtamembrane domain of FMS-like tyrosine kinase 3 (FLT3) represent a poor prognostic indicator in acute myeloid leukemia (AML). Therapeutic benefits of tyrosine k...

    Authors: Xin You, Weiye Jiang, Wenhua Lu, Hui Zhang, Tiantian Yu, Jingyu Tian, Shijun Wen, Guillermo Garcia-Manero, Peng Huang and Yumin Hu

    Citation: Cancer Communications 2019 39:17

    Published on:

  15. Content type: Original article

    The benefit of systemic treatments in esophageal squamous cell carcinoma (ESCC) which has progressed after chemotherapy is still uncertain and optimal regimens based on randomized trials have not yet been esta...

    Authors: Jing Huang, Binghe Xu, Ying Liu, Junxing Huang, Ping Lu, Yi Ba, Lin Wu, Yuxian Bai, Shu Zhang, Jifeng Feng, Ying Cheng, Jie Li, Lu Wen, Xianglin Yuan, Changwu Ma, Chunhong Hu…

    Citation: Cancer Communications 2019 39:16

    Published on:

  16. Content type: Original article

    Currently, the diagnosis and treatment of nasopharyngeal carcinoma (NPC) patients with residual cervical lymphadenopathy following radical radiotherapy with or without chemotherapy are challenging. We investig...

    Authors: Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, Lin-Quan Tang, Qiu-Yan Chen, Huan-Xin Lin, Yu-Jing Liang, Jin-Jie Yan, Chao Lin, Shan-Shan Guo, Li-Ting Liu, Yang Li, Hao-Jun Xie, Qing-Nan Tang, Hu Liang, Ling Guo…

    Citation: Cancer Communications 2019 39:14

    Published on:

  17. Content type: Review

    Robust and clinically convenient biomarkers for cancer diagnosis, early detection, and prognosis have great potential to improve patient survival and are the key to precision medicine. The advent of next-gener...

    Authors: Chang Zeng, Emily Kunce Stroup, Zhou Zhang, Brian C.-H. Chiu and Wei Zhang

    Citation: Cancer Communications 2019 39:12

    Published on:

  18. Content type: Guideline and Consensus

    China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment p...

    Authors: Feng-Hua Wang, Lin Shen, Jin Li, Zhi-Wei Zhou, Han Liang, Xiao-Tian Zhang, Lei Tang, Yan Xin, Jing Jin, Yu-Jing Zhang, Xiang-Lin Yuan, Tian-Shu Liu, Guo-Xin Li, Qi Wu, Hui-Mian Xu, Jia-Fu Ji…

    Citation: Cancer Communications 2019 39:10

    Published on:

  19. Content type: Original article

    Identification of activated epidermal growth factor receptor (EGFR) mutations and application of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) have greatly changed the therapeutic strategies of non-small-cell lung ...

    Authors: Fang Wang, Xia-Yao Diao, Xiao Zhang, Qiong Shao, Yan-Fen Feng, Xin An and Hai-Yun Wang

    Citation: Cancer Communications 2019 39:7

    Published on:

  20. Content type: Correction

    In the original publication of this article [1], the number of death cases in ‘Materials and methods’ section is incorrect.

    Authors: Jie Liu, Xu-li Yang, Si-Wei Zhang, Li-Ping Zhu and Wan-Qing Chen

    Citation: Cancer Communications 2019 39:6

    Published on:

    The original article was published in Cancer Communications 2018 38:75

  21. Content type: Study Protocol

    Glioblastoma (GBM) is a highly virulent tumor of the central nervous system, with a median survival < 15 months. Clearly, an improvement in treatment outcomes is needed. However, the emergence of these maligna...

    Authors: Lin Kong, Jing Gao, Jiyi Hu, Rong Lu, Jing Yang, Xianxin Qiu, Weixu Hu and Jiade J. Lu

    Citation: Cancer Communications 2019 39:5

    Published on:

  22. Content type: Original article

    Little is known about the correlation between the clinicopathological features, postoperative treatment, and prognosis of multiple gastric cancers (MGCs). In this study, we aimed to investigate the correlation...

    Authors: Jian-Xian Lin, Zu-Kai Wang, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Ze-Ning Huang, Ju-Li Lin, Chao-Hui Zheng, Chang-Ming Huang and Ping Li

    Citation: Cancer Communications 2019 39:4

    Published on:

  23. Content type: Original article

    In our previous study, we identified a candidate tumor suppressor gene, testin LIM domain protein (TES), in primary gastric cancer (GC). TES contains three LIM domains, which are specific interacting regions for ...

    Authors: Dan-dan Wang, Yi-bing Chen, Jing-jing Zhao, Xiao-fei Zhang, Guang-chao Zhu, De-sheng Weng, Ke Pan, Lin Lv, Qiu-zhong Pan, Shan-shan Jiang, Lei-lei Wang and Jian-chuan Xia

    Citation: Cancer Communications 2019 39:3

    Published on:

  24. Content type: Original article

    Epithelial–mesenchymal transition (EMT) is implicated in the metastatic process and presents a challenge to epithelial cell adhesion molecule-based detection of circulating tumor cells (CTCs), which have been ...

    Authors: Xiuwen Guan, Fei Ma, Chunxiao Li, Shiyang Wu, Shangying Hu, Jiefen Huang, Xiaoying Sun, Jiayu Wang, Yang Luo, Ruigang Cai, Ying Fan, Qiao Li, Shanshan Chen, Pin Zhang, Qing Li and Binghe Xu

    Citation: Cancer Communications 2019 39:1

    Published on:

  25. Content type: Original article

    Thus far, the incidence, mortality, and temporal trend data of oropharyngeal cancers (OPC) in China were few. We estimated the incidence, mortality, and temporal patterns of OPC in China during 2008–2012 accor...

    Authors: Jie Liu, Xu-li Yang, Si-Wei Zhang, Li-Ping Zhu and Wan-Qing Chen

    Citation: Cancer Communications 2018 38:75

    Published on:

    The Correction to this article has been published in Cancer Communications 2019 39:6

  26. Content type: Original article

    Postradiation nasopharyngeal necrosis (PRNN) is a severe complication after radiotherapy in patients with nasopharyngeal carcinoma (NPC), which can severely affect the quality of life and threaten the patient’...

    Authors: Xiong Zou, Shun-Lan Wang, You-Ping Liu, Yan-Ling Liu, Ru-Hai Zou, Yi-Nuan Zhang, Rui You, Qi Yang, Yu-Long Xie, Mei Lin, Pei-Yu Huang, Rou Jiang, Meng-Xia Zhang, Chao-Nan Qian, Hai-Qiang Mai, Ling Guo…

    Citation: Cancer Communications 2018 38:74

    Published on:

  27. Content type: Original article

    The preliminary results of our phase II randomized trial reported comparable functional sphincter preservation rates and short-term survival outcomes between patients undergoing total mesorectal excision (TME)...

    Authors: Fulong Wang, Wenhua Fan, Jianhong Peng, Zhenhai Lu, Zhizhong Pan, Liren Li, Yuanhong Gao, Hui Li, Gong Chen, Xiaojun Wu, Peirong Ding, Zhifan Zeng and Desen Wan

    Citation: Cancer Communications 2018 38:73

    Published on:

Affiliated with

Annual Journal Metrics